Caixin Securities·2025-09-18 23:30Market Strategy - The market experienced a pullback after a brief rise, with total trading volume exceeding 30 trillion yuan [5][7] - The Shanghai Composite Index fell by 1.15% to close at 3831.66 points, while the ChiNext Index dropped by 1.64% to 3095.85 points [7][9] - The technology sector remained active, particularly in semiconductor and computing hardware, while other sectors like non-bank financials and materials lagged [8][9] Important Economic News - The People's Bank of China conducted a 487 billion yuan reverse repurchase operation with a 1.40% interest rate, resulting in a net injection of 195 billion yuan [14][15] - The Federal Reserve lowered interest rates by 25 basis points to a range of 4.00%-4.25%, marking the first rate cut in nine months [16][17] - In August, the postal industry in China saw a revenue increase of 4.4% year-on-year, with total revenue reaching 142.99 billion yuan [18][19] - By the end of August, the number of electric vehicle charging infrastructure units in China grew by 53.5% year-on-year, totaling 17.348 million units [20][21] Industry and Company Dynamics - JD Group and Giant Dragon Technology have formed a strategic partnership, successfully delivering their first batch of electric two-wheelers [25][26] - In August 2025, China's securities transaction stamp duty saw a significant increase of 226% year-on-year, with total revenue reaching 25.1 billion yuan [27][28] - Tesla signed a letter of intent with PharmAGRI to supply up to 10,000 Optimus 3+ robots for agricultural operations [29][30] - Meta launched AI smart glasses with a built-in display, starting at a price of $799, featuring new interaction methods [31][32][34] - In August, the average operating rate of engineering machinery in China was 43.42%, with Zhejiang province leading in performance [35][36] - TCL Technology announced plans to invest in an 8.6-generation printed OLED production line, with a total investment of approximately 29.5 billion yuan [37][39] - Meikang Bio obtained four medical device registration certificates for in vitro diagnostic reagents, enhancing its product portfolio [40][41]